JJP Biologics is a pre-clinical stage biotechnology company. They specialize in developing therapeutic monoclonal antibodies with companion diagnostics for personalized treatment, with a main focus on innovative biologics for autoimmune diseases and cancer. They have a team experienced in bringing new biologics to the market and a range of programs including JJP-1212 and JJP-1008. The company is open to collaborating with scientific partners and potential investors.
Headquarters
Ul. Bobrowiecka 6
Warsaw; Mazowieckie;
Postal Code: 00-728
Contact Details: Purchase the Jjp Biologics Sp. z o.o. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service